Ethics and transparency

Health policy

Policy-making and legislation have an essential impact on our business. Likewise, our activities have an influence on society and the public sector. We believe that sharing our expertise and communicating our positions contribute responsibly to policy-making and are part of our engagement as corporate citizen. Our knowledge and expertise are offered to policy-makers and other relevant stakeholders on a wide range of issues affecting our business by means of constructive dialogue. We work and cooperate with health-policy experts and trade organizations on a national and global scale. The guiding principle we apply to our corporate public affairs activities is transparency. As part of our ongoing commitment to transparency we state our positions on different public policy issues affecting our business. We are convinced that the societal challenges are best solved jointly by all relevant stakeholders.

Our Codes of Conduct

In order to further the ethical conduct between the pharmaceutical industry and the healthcare profession as well as patient organisations, industry codes have been implemented by the pharmaceutical industry associations on international, regional and national level.

Bayer has committed itself to adhere in all its promotional activities to the rules/codes set by the following associations: the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), the European Federation of Pharmaceutical Industries and Associations (EFPIA) and the association “Freiwillige Selbstkontrolle für die Arzneimittelindustrie e.V.” (FSA) (“Voluntary Self-regulation for the Pharmaceutical Industry”).